太醫

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

77.6049成交張數12.98本益比1.97股價淨值比5.80%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	42	29	31.8%	2.35	39.35	15.5%	10.5%	1.9	1.8
2026Q1	40	31	22.8%	3.99	42.31	11.5%	8.9%	0.8	0.7
2025Q4	39	30	24.3%	3.49	40.87	13.0%	9.8%	2.0	2.0
2025Q3	38	29	23.9%	3.46	39.59	14.1%	10.7%	1.1	0.9
2025Q2	41	27	32.3%	2.21	37.79	14.9%	10.1%	1.7	1.6
2025Q1	40	31	23.1%	3.81	42.35	15.7%	12.0%	0.7	0.6
2024Q4	39	29	24.2%	3.40	40.53	15.5%	11.7%	1.9	1.8
2024Q3	37	28	24.3%	3.47	38.91	14.8%	11.2%	1.3	1.2
2024Q2	40	27	31.9%	2.12	37.09	15.2%	10.4%	1.2	1.1
2024Q1	38	29	23.6%	3.42	40.51	14.4%	10.9%	0.6	0.6
2023Q4	38	28	24.8%	3.03	39.03	15.2%	11.3%	2.5	2.4
2023Q3	36	28	24.0%	3.11	38.01	16.8%	12.7%	1.2	1.1
2023Q2	38	26	31.3%	2.02	36.31	17.2%	11.6%	1.1	1.0
2023Q1	37	28	24.4%	2.96	38.98	13.9%	10.4%	1.8	1.7
2022Q4	36	27	25.5%	2.64	37.42	12.2%	8.9%	1.8	1.7
2022Q3	35	26	25.7%	2.47	35.90	10.2%	7.2%	0.9	0.9
2022Q2	37	25	33.2%	1.80	34.35	13.7%	9.5%	1.2	1.2
2022Q1	38	28	26.6%	3.45	38.04	13.1%	9.3%	0.3	0.3
2021Q4	38	27	28.7%	3.22	37.27	14.5%	10.0%	1.1	1.1
2021Q3	40	27	33.3%	2.02	36.62	16.4%	10.8%	0.6	0.5
2021Q2	39	28	28.9%	2.86	37.99	11.7%	7.6%	0.6	0.5
2021Q1	39	27	31.0%	2.65	37.18	13.1%	8.7%	0.9	0.8
2020Q4	39	26	33.8%	2.56	36.01	12.7%	8.3%	2.1	1.8
2020Q3	39	25	34.6%	2.64	34.92	19.4%	11.9%	1.3	1.2
2020Q2	41	25	39.6%	1.87	37.12	20.2%	11.7%	1.5	1.3
2020Q1	41	26	35.6%	2.75	39.62	18.7%	11.5%	0.8	0.7
2019Q4	39	26	35.4%	2.64	38.65	18.9%	12.2%	0.9	0.6
2019Q3	41	23	42.9%	2.10	35.30	13.3%	7.9%	1.1	0.9
2019Q2	41	23	44.7%	1.56	34.10	13.0%	7.5%	1.4	0.3
2019Q1	40	24	41.0%	1.68	35.92	10.2%	6.3%	1.2	1.0
2018Q4	36	23	35.5%	1.56	35.01	9.5%	6.0%	1.7	1.1
2018Q3	37	22	38.6%	1.44	33.96	8.4%	5.1%	0.7	0.3
2018Q2	36	22	40.3%	1.25	32.94	9.3%	5.4%	0.8	0.2
2018Q1	36	23	36.7%	1.54	34.80	9.4%	6.1%	0.3	-0.6
2017Q4	36	23	37.9%	1.32	34.24	10.7%	6.8%	1.1	0.6
2017Q3	37	22	39.6%	1.42	33.64	11.8%	7.5%	1.5	0.8
2017Q2	37	21	42.2%	1.09	32.44	12.2%	7.5%	0.9	0.4
2017Q1	34	23	33.1%	1.65	34.10	13.2%	9.4%	0.6	0.2
2016Q4	33	22	34.1%	1.45	33.17	–	–	0.8	-1.6
2016Q3	31	21	32.1%	1.73	32.26	–	–	0.5	-1.7